Shareholder Votes

First Watch Restaurant Group, Inc. shareholders approved Election of Class II Directors at the 2026-05-20 meeting.

“The stockholders elected each of the three nominees named below as Class II directors to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier resignation or removal.”

ANI PHARMACEUTICALS INC shareholders approved Approval of the Amended 2022 Stock Plan.

“The vote with respect to the approval of the Amended 2022 Stock Plan was as follows: For Against Abstain Broker Non-Votes 13,806,050 1,080,387 9,388 2,030,222”

ANI PHARMACEUTICALS INC shareholders approved Approval of the frequency of future advisory votes to approve the compensation of the Company’s named executive officers, on an advisory basis.

“The vote with respect to the approval of the frequency of future advisory votes on the compensation of the Company’s named executive officers was as follows: ONE YEAR TWO YEARS THREE YEARS Abstain Broker Non-Votes 14,412,299 4,947 467,236 11,343 2,030,222”

ANI PHARMACEUTICALS INC shareholders approved Approval of the compensation of the Company’s named executive officers, on an advisory basis.

“The vote with respect to the approval of the compensation of the Company’s named executive officers, on an advisory basis, was as follows: For Against Abstain Broker Non-Votes 13,819,988 1,058,460 17,377 2,030,222”

ANI PHARMACEUTICALS INC shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-12-31 meeting.

“The vote with respect to the ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was as follows: For Against Abstain 16,874,103 7,333 44,611”

ANI PHARMACEUTICALS INC shareholders approved Election of seven director nominees.

“The vote with respect to the election of each of the director nominees was as follows: Nominees For Against Abstain Broker Non-Votes Thomas Haughey 14,732,894 159,765 3,166 2,030,222 Nikhil Lalwani 14,873,796 15,198 6,831 2,030,222 Matthew J. Leonard, R.Ph. 14,743,471 149,095 3,259 2,030,222 Antonio R. Pera 14,542,012 350,649 3,164 2,030,222 Muthusamy Shanmugam 14,849,624 42,253 3,948 2,030,222 Renee P. Tannenbaum, Pharm.D. 14,063,620 829,566 2,639 2,030,222 Jeanne A. Thoma 14,565,758 327,393 2,674 2,030,222”

Pattern Group Inc. shareholders approved Non-binding advisory vote on the frequency of future Say on Pay Votes at the 2026-05-15 meeting.

“Proposal 4 – Say on Frequency Vote The stockholders approved the Board’s recommendation of “every year” in the non-binding advisory vote on the frequency of future Say on Pay Votes (the “Say on Frequency Vote”), by voting as follows:”

Pattern Group Inc. shareholders approved Approval, on an advisory (non-binding) basis, of the compensation paid by the Company to its named executive officers at the 2026-05-15 meeting.

“Proposal 3 – Say on Pay Vote The approval, on an advisory (non-binding) basis, of the compensation paid by the Company to its named executive officers (the “Say on Pay Vote”), was approved by the following vote:”

Pattern Group Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-15 meeting.

“Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The ratification of the Audit Committee’s appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026, was approved by the following vote:”

Pattern Group Inc. shareholders approved Election of Directors at the 2026-05-15 meeting.

“Proposal 1 – Election of Directors The election of the individuals named below as members of the Board of Directors, to serve for a term of three years ending at the 2029 annual meeting of stockholders and until such person’s respective successor has been duly elected and qualified or until such person’s earlier death, resignation, or removal, was approved by the following vote:”

CuriosityStream Inc. shareholders approved Advisory vote on frequency of future advisory votes on executive compensation at the 2026-05-20 meeting.

“Proposal 5 - The Frequency of Future Advisory Votes on Executive Compensation VOTES FOR 1 YEAR VOTES FOR 2 YEARS VOTES FOR 3 YEARS ABSTAIN 34,545,744 38,924 685,445 126,485”

CuriosityStream Inc. shareholders approved Advisory approval of executive compensation at the 2026-05-20 meeting.

“Proposal 4 - Approval, on an Advisory Basis, of Executive Compensation VOTES FOR VOTES AGAINST ABSTAIN BROKER NON-VOTES 32,090,139 3,110,056 26,874 8,391,971”

CuriosityStream Inc. shareholders approved Ratification of appointment of Grant Thornton LLP as independent auditor for fiscal year 2026 at the 2026-05-20 meeting.

“Proposal 3 - Ratification of Appointment of Independent Auditor VOTES FOR VOTES AGAINST ABSTAIN 44,237,825 81,585 39,788”

CuriosityStream Inc. shareholders rejected Approval of amendment to 2020 Omnibus Incentive Plan to increase shares from 10,725,000 to 11,725,000 at the 2026-05-20 meeting.

“Proposal 2 - Approval of Amendment to Omnibus Incentive Plan VOTES FOR VOTES AGAINST ABSTAIN BROKER NON-VOTES 28,879,878 6,447,041 69,788 8,962,600”

CuriosityStream Inc. shareholders approved Election of three Class III directors at the 2026-05-20 meeting.

“Proposal 1 - Election of Directors DIRECTOR NOMINEES VOTES FOR WITHHELD BROKER NON-VOTES Matthew Blank 27,934,848 7,461,750 8,962,600 Jonathan Huberman 34,271,492 1,125,106 8,962,600 Mike Nikzad 30,462,987 4,933,611 8,962,600”

Hyperfine, Inc. shareholders approved Ratification of Grant Thornton LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-21 meeting.

“The appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified, based on the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 341,824,976 3,658,781 209,580 —”

Hyperfine, Inc. shareholders approved Election of Directors at the 2026-05-21 meeting.

“The following nominees were reelected to serve on the Company's Board of Directors until the Company’s 2027 annual meeting of stockholders and until their respective successors have been elected and qualified, based on the following votes: Name Votes For Votes Against Votes Abstained Broker Non-Votes Daniel J. Wolterman 314,507,148 1,119,985 74,738 29,991,466 Maria Sainz 314,632,923 996,652 72,296 29,991,466 John Dahldorf 314,717,927 909,207 74,737 29,991,466 Ruth Fattori 314,704,628 925,051 72,192 29,991,466 Jonathan M. Rothberg, Ph.D. 315,051,080 574,206 76,585 29,991,466”

KORU Medical Systems, Inc. shareholders approved Ratification of the appointment of independent registered accountants for the 2026 fiscal year at the 2026-05-19 meeting.

“Proposal 5: Ratification of the appointment of independent registered accountants for the 2026 fiscal year. The Company’s shareholders ratified the appointment of Cherry Bekaert LLP as the company’s independent registered public accountants for the 2026 fiscal year.”

KORU Medical Systems, Inc. shareholders approved Advisory approval of the frequency of future votes on executive compensation at the 2026-05-19 meeting.

“Proposal 4: Advisory approval of the frequency of future votes on executive compensation. The Company’s shareholders, on an advisory basis, approved the frequency of future votes on executive compensation to be every one year.”

KORU Medical Systems, Inc. shareholders approved Advisory approval of the compensation of the Company’s executive officers at the 2026-05-19 meeting.

“Proposal 3: Advisory approval of the compensation of the Company’s executive officers. The Company’s shareholders, on an advisory basis, approved the compensation of the Company’s executive officers.”

KORU Medical Systems, Inc. shareholders approved Approval of an amendment to the 2024 Omnibus Equity Incentive Plan to increase the available number of shares at the 2026-05-19 meeting.

“Proposal 2: Approval of an amendment to the 2024 Omnibus Equity Incentive Plan to increase the available number of shares. The Company’s shareholders approved the amendment to the 2024 Omnibus Equity Incentive Plan to increase the available number of shares.”

KORU Medical Systems, Inc. shareholders approved Election of Directors at the 2026-05-19 meeting.

“Proposal 1: Election of Directors The nominees for director set forth under “Nominees” below were elected to the Company’s board of directors.”

VERISIGN INC/CA shareholders rejected Stockholder Proposal Regarding Independent Board Chairman Policy.

“Proposal No. 5 – Stockholder Proposal Regarding Independent Board Chairman Policy The Company’s stockholders voted against a stockholder proposal regarding a policy to require an independent board chairman. The voting results were as follows: For: 17,816,830 Against: 58,611,011 Abstain: 142,541 Broker Non-Votes: 5,136,483”

VERISIGN INC/CA shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2026-12-31 meeting.

“Proposal No. 4 – Ratification of the Selection of Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The voting results were as follows: For: 76,128,673 Against: 5,532,200 Abstain: 45,992”

VERISIGN INC/CA shareholders approved Approval of the Amendment and Restatement of the Company's 2006 Equity Incentive Plan.

“Proposal No. 3 – Approval of the Amendment and Restatement of the Company's 2006 Equity Incentive Plan The Company's stockholders approved the Amendment and Restatement of the 2006 Equity Incentive Plan. The voting results were as follows: For: 74,722,565 Against: 1,656,604 Abstain: 191,213 Broker Non-Votes: 5,136,483”

VERISIGN INC/CA shareholders approved To Approve, on a Non-Binding, Advisory Basis, the Company’s Executive Compensation.

“Proposal No. 2 – To Approve, on a Non-Binding, Advisory Basis, the Company’s Executive Compensation The Company’s stockholders approved, on a non-binding, advisory basis, the Company’s executive compensation. The voting results were as follows: For: 73,151,707 Against: 3,213,712 Abstain: 204,963 Broker Non-Votes: 5,136,483”

VERISIGN INC/CA shareholders approved Election of Directors.

“The Company’s stockholders elected the nominees listed below as directors of the Company, each to serve until the Company’s next annual meeting of stockholders, or until a successor has been elected and qualified or until the director’s earlier resignation or removal. The voting results were as follows: Nominees For Against Abstain Broker Non-Votes D. James Bidzos 71,313,798 4,928,619 327,965 5,136,483 Courtney D. Armstrong 75,594,369 940,840 35,173 5,136,483 Yehuda Ari Buchalter 74,589,944 1,949,703 30,735 5,136,483 Kathleen A. Cote 69,148,982 5,570,904 1,850,496 5,136,483 Matthew J. Desch 55,667,984 20,863,958 38,440 5,136,483 Jamie S. Gorelick 67,793,746 8,732,757 43,879 5,136,483 Debra W. McCann 76,105,017 430,335 35,030 5,136,483”

OLIN Corp shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm for 2026 at the 2026-04-30 meeting.

“Votes For Votes Against Abstentions Broker Non-Votes Proposal 4 96,697,914 1,974,822 151,501 0”

NCR Atleos Corp shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-21 meeting.

“The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 was ratified by the votes set forth in the table below:”

NCR Atleos Corp shareholders approved Non-Binding and Advisory Vote to Approve the Compensation of Named Executive Officers as Disclosed in the Proxy Statement at the 2026-05-21 meeting.

“Executive compensation disclosed in the Company's Proxy Statement was approved, on a non-binding and advisory basis, by the votes set forth in the table below:”

NCR Atleos Corp shareholders approved Election of Directors at the 2026-05-21 meeting.

“Seven directors were elected to serve a term expiring at the Company's 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualify by the votes set forth in the table below:”

Kinsale Capital Group, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-21 meeting.

“Proposal 3 - Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstain 20,170,172 49,930 8,441”

Kinsale Capital Group, Inc. shareholders approved Advisory vote to approve the compensation of the Company’s named executive officers at the 2026-05-21 meeting.

“Proposal 2 - Advisory vote to approve the compensation of the Company’s named executive officers. For Against Abstain Broker Non-Votes 17,985,583 436,855 80,679 1,725,426”

Kinsale Capital Group, Inc. shareholders approved Election of nine directors at the 2026-05-21 meeting.

“Proposal 1 - Election of nine directors to serve on the Company’s board of directors until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified. For Against Abstain Broker Non-Votes Steven J. Bensinger 18,397,750 97,048 8,319 1,725,426”

UNIVERSAL ELECTRONICS INC shareholders approved Ratification of Grant Thornton LLP as independent auditor for 2026 at the 2026-05-19 meeting.

“5. The ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026: For Against Abstain 9,647,501 104,381 18,603”

UNIVERSAL ELECTRONICS INC shareholders approved Non-binding advisory vote on executive compensation at the 2026-05-19 meeting.

“4. The approval of, on a non-binding advisory basis, the compensation of the Company’s named executive officers: For Against Abstain Broker Non-Votes 5,572,215 2,277,201 285,618 1,635,451”

UNIVERSAL ELECTRONICS INC shareholders approved Amendment and restatement of the 2018 Equity and Incentive Compensation Plan to increase shares, extend term, and incorporate other amendments at the 2026-05-19 meeting.

“3. The adoption and approval of the amendment and restatement of the Company’s Amended and Restated 2018 Equity and Incentive Compensation Plan (a) to increase the number of shares of common stock available for issuance thereunder by 375,000 shares, (b) to extend the term thereof, and (c) to incorporate other amendments thereto consistent with current compensation and governance best practice: For Against Abstain Broker Non-Votes 7,406,445 705,417 23,172 1,635,451”

UNIVERSAL ELECTRONICS INC shareholders approved Amendment to Restated Certificate of Incorporation to declassify the Board of Directors at the 2026-05-19 meeting.

“2. The adoption and approval of an amendment to the Company’s Restated Certificate of Incorporation, as amended, to declassify the Company’s Board of Directors (the “Charter Amendment Proposal”): For Against Abstain Broker Non-Votes 7,719,323 387,784 27,927 1,635,451”

UNIVERSAL ELECTRONICS INC shareholders approved Election of Class II directors at the 2026-05-19 meeting.

“1. The election of the following Class II directors to serve on the Company’s Board of Directors until the annual meeting of stockholders to be held in 2028 or until their respective successors are elected and qualified (the “Director Election Proposal”): Director For Withhold Broker Non-Votes Michael D. Burger 7,525,057 609,977 1,635,451 Satjiv S. Chahil 7,008,595 1,126,439 1,635,451 Sue Ann R. Hamilton 6,068,770 2,066,264 1,635,451 John Mutch 7,582,585 552,449 1,635,451 Eric B. Singer 6,306,980 1,828,054 1,635,451”

AVIS BUDGET GROUP, INC. shareholders rejected Shareholder Proposal Regarding Governance by Majority Voting and Meeting Adjournment at the 2026-05-20 meeting.

“Proposal No. 4. Shareholder Proposal Regarding Governance by Majority Voting and Meeting Adjournment. The shareholder proposal to approve, on an advisory basis, a request that the Company’s Board of Directors take each step necessary so that each voting requirement in the Company’s charter and bylaws that calls for a greater than simple majority vote be replaced by the applicable majority vote standard and to adjourn the applicable shareholder meeting, for up to 2 weeks, if the proposal fails to obtain the required 80% shareholder approval vote on the date of such meeting, was not approved, and received the following votes:”

AVIS BUDGET GROUP, INC. shareholders approved Advisory Approval of the Compensation of the Company’s Named Executive Officers at the 2026-05-20 meeting.

“Proposal No. 3. Advisory Approval of the Compensation of the Company’s Named Executive Officers. The proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers, as described in the Company’s 2026 proxy statement, was approved by the following votes:”

AVIS BUDGET GROUP, INC. shareholders approved Ratification of Appointment of Auditors at the 2026-05-20 meeting.

“Proposal No. 2. Ratification of Appointment of Auditors. The proposal to ratify the appointment of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for fiscal year 2026 was approved by the following votes:”

AVIS BUDGET GROUP, INC. shareholders approved Election of Directors at the 2026-05-20 meeting.

“Proposal No. 1. Election of Directors. The six nominees named in the Company’s 2026 proxy statement were elected as directors to serve a one-year term expiring in 2027 and until their successors are duly elected and qualified or until their earlier resignation or removal, based upon the following votes:”

TANDEM DIABETES CARE INC shareholders approved To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-05-20 meeting.

“Proposal 6 : To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. This proposal was approved and the voting results were as follows: For Against Abstain Broker Non-Votes 57,493,084 454,735 16,556 0”

TANDEM DIABETES CARE INC shareholders approved To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other change at the 2026-05-20 meeting.

“Proposal 5 : To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changes based on updates to the DGCL. This proposal was approved and the voting results were as follows: For Against Abstain Broker Non-Votes 45,926,405 9,043,831 15,058 2,979,081”

TANDEM DIABETES CARE INC shareholders approved To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the DGCL. at the 2026-05-20 meeting.

“Proposal 4 : To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the DGCL. This proposal was approved and the voting results were as follows: For Against Abstain Broker Non-Votes 57,818,029 126,025 20,321 0”

TANDEM DIABETES CARE INC shareholders approved To approve the Amended Plan to, among other things, increase the number of shares authorized for issuance under the plan. at the 2026-05-20 meeting.

“Proposal 3 : To approve the Amended Plan to, among other things, increase the number of shares authorized for issuance under the plan. This proposal was approved and the voting results were as follows: For Against Abstain Broker Non-Votes 53,846,696 1,108,529 30,069 2,979,081”

TANDEM DIABETES CARE INC shareholders approved To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in the Proxy Statement. at the 2026-05-20 meeting.

“Proposal 2 : To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as described in the Proxy Statement. This proposal was approved and the voting results were as follows: For Against Abstain Broker Non-Votes 53,460,747 1,481,027 43,520 2,979,081”

TANDEM DIABETES CARE INC shareholders approved To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders. at the 2026-05-20 meeting.

“Proposal 1 : To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders. The stockholders elected nine directors by the following votes: Name of Director For Against Abstain Broker Non-Votes Rebecca Robertson 54,160,282 799,310 25,702 2,979,081 Sandra Beaver 54,607,191 348,050 30,053 2,979,081 Myoungil Cha 54,456,358 502,290 26,646 2,979,081 Peyton Howell 54,179,597 773,220 32,477 2,979,081 Joao Malagueira 54,454,159 499,747 31,388 2,979,081 Kathleen McGroddy-Goetz 54,312,399 641,726 31,169 2,979,081 John Sheridan 54,432,569 536,164 16,561 2,979,081 2 Rajwant Sodhi 54,328,131 621,295 35,868 2,979,081 Christopher Twomey 47,921,655 7,034,208 29,431 2,979,081”

Avidbank Holdings, Inc. shareholders approved Ratification of the appointment of Crowe LLP as the independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-19 meeting.

“The Company’s shareholders ratified the appointment of Crowe LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”